Rinsulin NPH (Geropharm)
- Generic Name
- Rinsulin NPH (Geropharm)
Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method
Not Applicable
Completed
- Conditions
- BioequivalencePharmacokinetics
- Interventions
- First Posted Date
- 2020-08-06
- Last Posted Date
- 2020-08-06
- Lead Sponsor
- Geropharm
- Target Recruit Count
- 52
- Registration Number
- NCT04501250
- Locations
- 🇷🇺
Yarosslavl Clinical Hospital #3, Yaroslavl, Russian Federation
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath